About Recursion Pharmaceuticals
Recursion Pharmaceuticals is a company based in New York (United States) founded in 2013.. Recursion Pharmaceuticals has raised $456.66 million across 21 funding rounds from investors including Nvidia, Intermountain Healthcare and Bayer. Recursion Pharmaceuticals has completed 4 acquisitions, including Cyclica, Exscientia and Valence Labs. Recursion Pharmaceuticals offers products and services including BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform. Recursion Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, BridgeBio, Moderna, C4 Therapeutics and Spark Therapeutics, among others.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Recursion Pharmaceuticals, Inc.
-
Annual Revenue
$58.84 M32as on Dec 31, 2024
-
Net Profit
$-463.66 M-41.33as on Dec 31, 2024
-
EBITDA
$-442.51 M-39.33as on Dec 31, 2024
-
Total Equity Funding
$456.66 M (USD)
in 21 rounds
-
Latest Funding Round
$6 M (USD), Seed
Feb 29, 2024
-
Investors
Nvidia
& 34 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cyclica
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Recursion Pharmaceuticals
Recursion Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol RXRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Recursion Pharmaceuticals
Recursion Pharmaceuticals offers a comprehensive portfolio of products and services, including BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supercomputer for processing large-scale biological and chemical data.
AI agent for drug discovery processes and data analysis.
Integrated platform for AI-enabled gene and compound profiling.
Unlock access to complete
Unlock access to complete
Leadership Team
32 people
Data Analysis and Operations Team
30 people
Software Development Team
21 people
Senior Team
12 people
Product Management Team
11 people
Board Team
8 people
Operations Team
7 people
Finance and Accounting
6 people
Unlock access to complete
Funding Insights of Recursion Pharmaceuticals
Recursion Pharmaceuticals has successfully raised a total of $456.66M across 21 strategic funding rounds. The most recent funding activity was a Seed round of $6 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 21
- Last Round Seed — $6.0M
-
First Round
First Round
(01 Jan 2014)
- Investors Count 35
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Seed - Recursion Pharmaceuticals | Valuation |
investors |
|
| Jul, 2023 | Amount | Post-IPO - Recursion Pharmaceuticals | Valuation |
investors |
|
| Oct, 2022 | Amount | Post-IPO - Recursion Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Recursion Pharmaceuticals
Recursion Pharmaceuticals has secured backing from 35 investors, including institutional and venture fund investors. Prominent investors backing the company include Nvidia, Intermountain Healthcare and Bayer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward multiple sectors by Kinnevik.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Recursion Pharmaceuticals
Recursion Pharmaceuticals has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cyclica, Exscientia and Valence Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Research and productization engine within Recursion that focuses on advancing the frontier of AI in drug discovery
|
2017 | ||||
|
Provider of living informatics platform for preclinical in vivo drug research
|
2013 | ||||
|
AI-driven drug discovery and precision medicine solutions are provided.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Recursion Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Recursion Pharmaceuticals Comparisons
Competitors of Recursion Pharmaceuticals
Recursion Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, BridgeBio, Moderna, C4 Therapeutics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Recursion Pharmaceuticals
Frequently Asked Questions about Recursion Pharmaceuticals
When was Recursion Pharmaceuticals founded?
Recursion Pharmaceuticals was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Recursion Pharmaceuticals located?
Recursion Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Recursion Pharmaceuticals a funded company?
Recursion Pharmaceuticals is a funded company, having raised a total of $456.66M across 21 funding rounds to date. The company's 1st funding round was a Post-IPO of $150M, raised on Jan 01, 2014.
What is the annual revenue of Recursion Pharmaceuticals?
Annual revenue of Recursion Pharmaceuticals is $58.84M as on Dec 31, 2024.
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals was founded in 2013 and is headquartered in New York, United States. Operations center on biotechnology, where an AI platform is applied to drug discovery and development. Biological and chemical datasets are analyzed alongside machine learning models and a supercomputer to identify targets and design molecules. Emphasis is given to conditions with unmet needs, including cancers and rare diseases. Strategic partnerships are pursued to broaden therapeutic applications.
Who are the top competitors of Recursion Pharmaceuticals?
Recursion Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Spark Therapeutics.
What products or services does Recursion Pharmaceuticals offer?
Recursion Pharmaceuticals offers BioHive Supercomputer, LOWE LLM Agent, and Recursion Platform.
Is Recursion Pharmaceuticals publicly traded?
Yes, Recursion Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol RXRX.
How many acquisitions has Recursion Pharmaceuticals made?
Recursion Pharmaceuticals has made 4 acquisitions, including Cyclica, Exscientia, and Valence Labs.
Who are Recursion Pharmaceuticals's investors?
Recursion Pharmaceuticals has 35 investors. Key investors include Nvidia, Intermountain Healthcare, Bayer, NIH, and Square 1 Bank.
What is Recursion Pharmaceuticals's ticker symbol?
The ticker symbol of Recursion Pharmaceuticals is RXRX on NASDAQ.